Product expansion SIRIO Europe is actively expanding its portfolio with Creatine+ gummies and LifeChews formats, presenting opportunities to offer contract development and manufacturing support for gummy and lipid-based ingredient delivery systems targeting sports nutrition and wellness sectors.

Habit-first platform The launch of Aeion, a habit-first longevity platform, signals potential for partnerships in consumer health programs, daily routine integration, and ongoing product customization services for brands seeking science-backed adherence strategies.

Innovation leadership With over 30 years in dosage form and ingredient innovation and a focus on new formats like high-potency solutions, Sirio Europe can be positioned as a strategic CDMO for brands needing advanced formulation capabilities and rapid market entry.

Nutraceutical momentum Recent activity around omega-3 lipid-based formulations and magnesium gummies aligns with growing wellness trends; there are opportunities to collaborate on scale-up manufacturing, regulatory support, and line extensions in the nutraceutical segment.

Strategic outreach As a European CDMO with a mid-sized team and global backing from the Sirio Pharma Group, there is a clear entry point for partnerships with brands seeking reliable manufacturing, supply chain resilience, and co-development across multiple dosage forms.